Dmitry Balyasny Balyasny Asset Management
Dmitry Balyasny is the founder of Balyasny Asset Management, a major multi-strategy and multi-manager hedge fund platform. The firm allocates capital across fundamental equities, macro, quant, and other teams under a central risk framework. Balyasny’s platform is often cited alongside other leading pod-shop multi-strategy firms.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPCX
SpaceX
SPCX
|
+$577M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$538M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$517M |
| 4 |
Texas Instruments
TXN
|
+$413M |
| 5 |
Roku
ROKU
|
+$356M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
HOLX
Hologic
HOLX
|
+$357M |
| 2 |
Meta Platforms (Facebook)
META
|
+$326M |
| 3 |
Johnson Controls International
JCI
|
+$303M |
| 4 |
Applied Materials
AMAT
|
+$285M |
| 5 |
CTRA
Coterra Energy
CTRA
|
+$285M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.69% |
| 2 | Industrials | 9.96% |
| 3 | Consumer Discretionary | 8.03% |
| 4 | Healthcare | 7.46% |
| 5 | Financials | 6.28% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
576
Neurogene
NGNE
$773M
| $25.7M | 0.03% |
818,706
+100,317
| +14% | +$2.76M |
|
577
PUT
Papa John's
PZZA
$788M
| $25.7M | 0.03% |
+700,000
| New | +$24.2M |
|
578
American Electric Power
AEP
$65.8B
| $25.7M | 0.03% |
188,030
+158,794
| +543% | +$20.9M |
|
|
ECHO
579
EchoStar
ECHO
$25.2B
| $25.6M | 0.03% |
252,369
-329,833
| -57% | -$40.3M |
|
|
580
CALL
Texas Instruments
TXN
$241B
| $25.5M | 0.03% |
85,500
+12,100
| +16% | +$3.36M |
|
581
Boot Barn
BOOT
$5.01B
| $25.4M | 0.03% |
+154,886
| New | +$25.1M |
|
582
CALL
GE Vernova
GEV
$255B
| $25.1M | 0.03% |
21,400
+10,600
| +98% | +$10.8M |
|
|
DEA
583
Easterly Government Properties
DEA
$1.16B
| $25M | 0.03% |
1,004,137
-67,415
| -6% | -$1.58M |
|
584
Four Corners Property Trust
FCPT
$2.77B
| $25M | 0.03% |
+1,017,401
| New | +$25.3M |
|
|
CTNM
585
Contineum Therapeutics
CTNM
$647M
| $25M | 0.03% |
1,522,793
-162,842
| -10% | -$2.13M |
|
586
PUT
Baidu
BIDU
$31.6B
| $24.9M | 0.03% |
217,800
-28,400
| -12% | -$3.52M |
|
587
Manhattan Associates
MANH
$12.5B
| $24.8M | 0.03% |
178,134
+94,172
| +112% | +$13M |
|
588
BCE
BCE
$22.1B
| $24.7M | 0.03% |
1,147,978
-740,806
| -39% | -$17.8M |
|
589
PUT
Verizon
VZ
$205B
| $24.7M | 0.03% |
582,900
+139,500
| +31% | +$6.54M |
|
590
AZZ Inc
AZZ
$4.25B
| $24.5M | 0.03% |
+158,310
| New | +$22.5M |
|
591
PUT
iShares China Large-Cap ETF
FXI
$4.28B
| $24.5M | 0.03% |
776,200
-69,100
| -8% | -$2.46M |
|
592
CALL
KLA
KLAC
$240B
| $24.5M | 0.03% |
81,100
-56,900
| -41% | -$11.3M |
|
593
Occidental Petroleum
OXY
$61.3B
| $24.5M | 0.03% |
503,765
-1,560,933
| -76% | -$88.6M |
|
|
594
CALL
Applied Materials
AMAT
$391B
| $24.4M | 0.03% |
33,800
-21,600
| -39% | -$9.97M |
|
595
IAMGOLD
IAG
$12.1B
| $24.3M | 0.03% |
1,534,135
+339,053
| +28% | +$5.92M |
|
596
Rezolute
RZLT
$490M
| $24.2M | 0.03% |
4,662,039
-386,382
| -8% | -$1.43M |
|
597
CALL
Chevron
CVX
$403B
| $24.2M | 0.03% |
146,200
+118,200
| +422% | +$22M |
|
|
DRUG
598
Bright Minds Biosciences
DRUG
$760M
| $24.2M | 0.03% |
345,053
+47,895
| +16% | +$3.76M |
|
599
CALL
iShares Expanded Tech-Software Sector ETF
IGV
$14.3B
| $24.2M | 0.03% |
267,300
+167,300
| +167% | +$14.9M |
|
600
TeraWulf
WULF
$7.8B
| $24.1M | 0.03% |
+976,767
| New | +$22.5M |
|
Similar funds
Dmitry Balyasny's Q2 2026 Portfolio in Review
As of Q2 2026, Dmitry Balyasny held 3,665 positions worth $80.2B, up 4% from $77.1B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Dmitry Balyasny withdrew a net $7.14B in Q2 2026, closing 734 positions and reducing 995 holdings. Its most notable exit was Hologic, an estimated $357M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.7% a quarter earlier, followed by Industrials and Consumer Discretionary.
Against the trend, Dmitry Balyasny opened a new position in SpaceX worth $581M.
- Dmitry Balyasny's largest Q2 2026 buy was SpaceX: 3,397,642 shares worth $581M.
- Dmitry Balyasny added most to State Street SPDR S&P 500 ETF Trust in Q2 2026, an estimated $538M increase.
- Dmitry Balyasny's biggest Q2 2026 reduction was Meta Platforms (Facebook), cutting an estimated $326M.
- Dmitry Balyasny fully exited Hologic in Q2 2026, selling an estimated $357M.
- Dmitry Balyasny's ten largest holdings make up 14% of its $80.2B portfolio in Q2 2026.
- Dmitry Balyasny opened 834 new positions and closed 734 in Q2 2026.
- Dmitry Balyasny's portfolio value rose 4% quarter-over-quarter to $80.2B.
Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.